Skip to search boxSkip to navigationSkip to main content

Melanoma cell lines from different stages of progression and their biological and molecular analyses

  • Kapaettu Satyamoorthy
    ,
  • Emma DeJesus
    ,
  • Alban J. Linnenbach
    ,
  • Barbara Kraj
    ,
  • Douglas L. Kornreich
    ,
  • Susan Rendle
*Corresponding author for this work
  • Wistar Institute
    ,
  • University of Pennsylvania
Scholary Output:
Contribution to journal
Article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

The biological and molecular characteristics of cell lines from metastatic melanomas have been extensively studied but less is known about cells from the biologically earliest stage of primary melanoma. The overall success rate of establishing permanent cell lines from such lesions is only 10% of that for biologically late primary or metastatic melanomas, although our laboratory now has eight cell lines available. The cells are immortal but show reduced or no proliferation in soft agar and immunodeficient mice when compared with primary melanomas from the biologically advanced vertical growth phase. Metastatic melanoma cell lines from patients with familial melanoma or xeroderma pigmentosum are biologically similar to those from patients with spontaneous melanomas. Irrespective of the malignant stages, deletions and mutations can occur in exons 1-3 of the p16(INK4A) gene. DNA fingerprinting was then employed to demonstrate the uniqueness of individual cell lines and to confirm the identity of cell lines derived from same patients. These cell lines are an excellent resource to investigate melanoma progression.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages S35-S42

Journal (Volume, Issue Number)

Melanoma Research (Volume 7, Issue SUPPL. 2)

Publication milestones

  • Published - 1997

Publication status

Published - 1997

ISSN

0960-8931

Publication IDs

  • Scopus: 0030853288
  • PubMed: 9578415

Publication metrics

Metrics

SciVal
FWCI
2.06
SciVal
Author count
8
SciVal
citations
133
SciVal
Paper percentile
96
SciVal
Top percentile
5
Fractional count
1
Fractional count
0.13
Fractional count
7
Fractional count
0.88
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Captures
26
Citation count
132

Funding Details

FunderFunding number
NCI
P01CA025874